The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 31, 2023
Filed:
Oct. 29, 2021
Applicant:
Venatorx Pharmaceuticals, Inc., Malvern, PA (US);
Inventors:
Christopher J. Burns, Malvern, PA (US);
Glen Coburn, Bethel, CT (US);
Bin Liu, Plainsboro, NJ (US);
Jiangchao Yao, Princeton, NJ (US);
Christopher Benetatos, Chester Springs, PA (US);
Steven A. Boyd, Chester Springs, PA (US);
Stephen M. Condon, Glenmoore, PA (US);
Thomas Haimowitz, Newtown, PA (US);
Assignee:
VENATORX PHARMACEUTICALS, INC., Malvern, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 487/04 (2006.01); C07D 207/34 (2006.01); A61P 31/20 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 417/12 (2006.01); C07D 403/06 (2006.01); C07D 498/04 (2006.01); C07D 401/06 (2006.01); C07D 403/12 (2006.01); C07D 413/12 (2006.01); C07D 413/14 (2006.01); C07D 471/04 (2006.01); C07D 513/04 (2006.01); C07D 207/337 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 409/12 (2006.01); C07D 409/14 (2006.01); C07F 5/02 (2006.01);
U.S. Cl.
CPC ...
C07D 207/34 (2013.01); A61P 31/20 (2018.01); C07D 207/337 (2013.01); C07D 401/06 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 498/04 (2013.01); C07D 513/04 (2013.01); C07F 5/025 (2013.01);
Abstract
Described herein are hepatitis B capsid assembly modulators and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for the treatment of hepatitis B.